5 Minutes with Carole Renouf
29 February 2016
What are you most excited about as you look towards leading MIA into the future?
Leadership for me is all about the fulfilment of potential. That’s my job – to help an organisation and its people achieve their greatest potential. I am excited about the wealth of potential at MIA. This is an organisation that, in the medical and scientific world, has already established a stellar reputation. Now it’s time to share that with other worlds, and invite them to be part of it and support it.
Why did you want to work with MIA and what are you hoping to achieve through your work?
Somehow, health and medical research has turned out to be my ‘space’. I think it’s because I believe health is our greatest asset. People with health problems –whatever these are - need the best possible treatments and care today, but they also need the promise that research brings – a better tomorrow. MIA is quite a unique organisation in that it brings together, on a daily basis, care and research for the betterment of people with melanoma and to prevent others getting melanoma. If together we can achieve those goals, I will be happy.
Where did you work before coming to MIA?
Before joining MIA, I worked at St Vincent’s, the National Breast Cancer Foundation and the Garvan Institute. I have always worked in the not for profit sector, although it was originally an unconscious rather than a conscious choice. I am interested in social change, so it’s a natural fit despite the many challenges – especially lack of resources.
What drives you as a CEO?
I don’t think leaders are born. I think they are made, and that they are made through confident humility and an openness to lifelong learning. I guess that defines me as a CEO.
It’s interesting to me that today, the ‘soft’ skills which I possess are now the ones that are most sought-after in CEOs. I always used to feel inadequate because the ‘hard’ skills (say, accounting or operations) were not my strengths. It feels good to know that the world has now caught up with the fact that the ability to inspire, unite, communicate and advocate counts!
What do you like to do in your spare time?
I live a very low key life outside of work. I am actually an introvert in an extrovert’s role, so I burn an enormous amount of energy at work. In my spare time I really need down time with no people around me and preferably outside enjoying nature. I love my daughter. I love the sea. I love animals. I love physical activity. I love travel (definitely not the journey but the destination). And I love reading, preferably crime fiction where every problem gets solved – unlike the real world!
Tell us something most people are surprised to learn about you?
I initiated and ran Australia’s first consensus conference. This is a fascinating Scandinavian method of equipping lay people to give informed advice to Governments about controversial issues in science, technology, education and more. It has often led to great changes in society and I am very proud to have introduced this methodology to Australia.
Melanoma Patients Australia Symposium - Webinar 2
Join us at the 2nd Melanoma Patients Australia webinar 'Psychological Health & Wellbeing'.
City2Surf 2020
You're invited to be a C2S charity superstar, and together we can run over melanoma!
City2Surf 2020
Join in the fun of the virtual event, and together we can run over melanoma!
Top melanoma experts from MIA
Melanoma Institute Australia features prominently in the latest ‘Expertise in Melanoma’ world rankings, released by Expertscape.
Melanoma Supportive Care Needs research study.
Participate in our online survey and help us understand the support needs of melanoma patients and carers.
New data reveals long-term benefit of adjuvant therapy for Stage III melanoma.
New online melanoma risk calculators critical to saving lives
Clinicians and their patients now have access to three online risk calculators developed by researchers at Melanoma Institute Australia.
Professor Richard Scolyer receives University of Sydney Alumni Award.
MIA's Co-Medical Director Professor Richard Scolyer has received The University of Sydney Alumni Award for International Achievement.
Uniting together despite the distance
More than 120 MIA clinicians, researchers and staff came together online to share research highlights.
Professor Richard Scolyer recognised in The Pathologist's 2020 Power List.
For the 2nd consecutive year, MIA's Co-Medical Director Professor Richard Scolyer has been selected in the top 100 best, brightest, and most powerful advocates of pathology by The Pathologist.
Important Update: Masks required at Poche Centre
As of Monday 27th July all patients and carers/family members coming into The Poche Centre will be required to bring their own mask.
A Critical Nexus:The Clinician and the Researcher.
In a recent issue of Cancer Cell journal, Prof Georgina Long AO and Prof Richard Scolyer discuss the challenge of bringing together clinical work and scientific research to underpin successful cancer research.
New online calculator launched to determine risk of spread of melanoma
Clinicians around the world now have access to a new online calculator that predicts the risk that a patient’s primary melanoma has spread to nearby lymph nodes.
Queen's Birthday Honour for Professor Georgina Long
Professor Long has been appointed as an Officer (AO) of the Order of Australia (General Division) for distinguished service to medicine, particularly, to melanoma clinical and translational research, and to professional medical societies.
Danny's inspiring survival story
“I had a complete response within about six months. All of my tumours disappeared."
MIA in the spotlight at ASCO virtual conference
‘We are extremely proud of our ongoing contribution to the global effort to save lives from melanoma, with Dr Silva’s prestigious award proof that we continue to lead the way,'
Professor Richard Scolyer achieves h-index of 100
MIA's Co-Medical Director, Professor Richard Scolyer, has achieved a Google Scholar h-index of 100.
See how we connected at Melanoma March Virtual 2020
We know what Melanoma March means to our community, so when we had to cancel our physical events, we created Melanoma March Virtual so that everyone across Australia could still connect to honour loved ones and support each other.
Melanoma meets its match.
A must-read personal account by Garry Maddox in The Sydney Morning Herald of how immunotherapy is revolutionising melanoma treatment.
Next Steps for National Screening Program for Melanoma
On Friday, a publication that lays out the steps needed to find out if a systematic screening program for melanoma would benefit all Australians was published in the Australia & New Zealand Journal of Public Health.